Plasmodium falciparum infection coinciding with the malaria vaccine candidate BK-SE36 administration interferes with the immune responses in Burkinabe children

BACKGROUND: A vaccine targeting the erythrocyte stages of Plasmodium falciparum could play a role in preventing clinical disease. BK-SE36 is a promising malaria vaccine candidate that has shown a good safety profile and immunological responses during field evaluations. It was observed that repeated...

Descripción completa

Detalles Bibliográficos
Autores principales: Tiono, Alfred B., Palacpac, Nirianne Marie Q., Bougouma, Edith Christiane, Nebie, Issa, Ouédraogo, Alphonse, Houard, Sophie, Arisue, Nobuko, D’Alessio, Flavia, Horii, Toshihiro, Sirima, Sodiomon B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10040972/
https://www.ncbi.nlm.nih.gov/pubmed/36993981
http://dx.doi.org/10.3389/fimmu.2023.1119820

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10040972/
https://www.ncbi.nlm.nih.gov/pubmed/36993981
http://dx.doi.org/10.3389/fimmu.2023.1119820

Ejemplares similares